Clinical Evidence Supporting US Food and Drug Administration Clearance of Novel Therapeutic Devices via the De Novo Pathway Between 2011 and 2019.

ABSTRACT:

SUBMITTER: Johnston JL 

PROVIDER: S-EPMC7551221 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature